H2O2 Signalling Pathway: A possible bridge between insulin receptor and mitochondria

Current Neuropharmacology

Volumn 10, Issue 4, 2012, Pages 311-320

  Pomytkin, Igor A ^a  

^a Biosignal Ltd   (Russian Federation)

Author keywords

Alzheimer's disease; Brain; Hydrogen peroxide; Insulin receptor; Mitochondria

Indexed keywords

HYDROGEN PEROXIDE; INSULIN RECEPTOR; PEROXIREDOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; SUPEROXIDE DISMUTASE;

AGING; ALZHEIMER DISEASE; APOPTOSIS; AUTOPHOSPHORYLATION; BIOGENESIS; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MICHAELIS MENTEN KINETICS; MITOCHONDRION; NEUROBLASTOMA; NEUROTOXICITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84874868212     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/157015912804143559     Document Type: Review

References (127)

1. Goldstein, B.J.; Mahadev, K.; Wu, X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes, 2005, 54(2), 311-321.
2. Mukherjee, S.P.; Lane, R.H.; Lynn, W.S. Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem. Pharmacol., 1978, 27(22), 2589-2594.
3. May, J.M.; de Haen, C. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J. Biol. Chem., 1979, 254(7), 2214-2220.
4. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest., 1992, 89(3), 1006-1013.
5. 2 generation in human adipocytes plasma membranes is mediated by Gαi2. J. Biol. Chem., 1997, 272(15), 10135-10143.
6. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol. 2004, 24(5), 1844-1854.
7. Mahadev, K.; Wu, X.; Zilbering, A.; Zhu, L.; Lawrence, J.T.R.; Goldstein, B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem., 2001, 276(52), 48662-48669.
8. Mahadev, K.; Zilbering, A.; Zhu, L.; Goldstein, B.J. Insulinstimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1B in vivo and enhances the early insulin action cascade. J. Biol. Chem., 2001, 276(24), 21938-21942.
9. Galic, S.; Hauser, C,; Kahn, B.B.; Haj, F.G.; Neel, B.G.; Tonks, N.K.; Tiganis, T. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol. Cell. Biol., 2005, 25(2), 819-829.
10. Banks, W.A. The source of cerebral insulin. Eur. J. Pharmacol., 2004, 490(1-3), 5-12.
11. White, M.F.; Kahn, C.R. The insulin signaling system. J. Biol. Chem., 1994, 269(1), 1-4.
12. Accili, D.; Drago, J.; Lee, E.J.; Johnson, M.D.; Cool, M.H.; Salvatore, P.; Asico, L.D.; Jose, P.A.; Taylor, S.I.; Westphal, H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet., 1996, 12(1), 106-109.
13. Joshi, R.L.; Lamothe, B.; Cordonnier, N.; Mesbah, K.; Monthioux, E.; Jami, J.; Bucchini, D. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J., 1996, 15(7), 1542-1547.
14. Hatfield, J.S.; Millard, W.J.; Smith, C.J. Short-term influence of intra-ventromedial hypothalamic administration of insulin on feeding in normal and diabetic rats. Pharmacol. Biochem. Behav., 1974, 2(2), 223-226.
15. Brief, D.J.; Davis, J.D. Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain. Res. Bull., 1984, 12(5), 571-575.
16. Brüning, J.C.; Gautam, D.; Burks, D.J.; Gillette, J.; Schubert, M.; Orban, P.C.; Klein, R.; Krone, W.; Müller-Wieland, D.; Kahn, C.R. Role of brain insulin receptor in control of body weight and reproduction. Science, 2000, 289(5487), 2122-2125.
17. Hirvonen, J.; Virtanen, K.A.; Nummenmaa, L.; Hannukainen, J.C.; Honka, M.J.; Bucci, M.; Nesterov, S.V.; Parkkola, R.; Rinne, J.; Iozzo, P.; Nuutila, P. Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes, 2011, 60(2), 443-447.
18. Zhao, W.Q.; Chen, H.; Quon, M.J.; Alkon, D.L. Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol., 2004, 490(1-3), 71-81.
19. Dou, J.T.; Chen, M.; Dufour, F.; Alkon, D.L.; Zhao, W.Q. Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn. Mem., 2005, 12(6), 646-655.
20. Niswender, K.D.; Morrison, C.D.; Clegg, D.J.; Olson, R.; Baskin, D.G.; Myers, M.G. Jr; Seeley, R.J.; Schwartz, M.W. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes, 2003, 52(2), 227-231.
21. Goldstein, B.J.; Dudley, A.L. The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. Mol. Endocrinol., 1990, 4, 235-244.
22. Mosthaf, L.; Grako, K.; Dull, T.J.; Coussens, L.; Ullrich, A.; McClain, D.A. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J., 1990, 9(8), 2409-2413.
23. Gammeltoft, S.; Fehlmann, M.; Van Obberghen, E. Insulin receptors in the mammalian central nervous system: binding characteristics and subunit structure. Biochimie, 1985, 67(10-11), 1147-1153.
24. Yamaguchi, Y.; Flier, J.S.; Yokota, A.; Benecke, H.; Backer, J.M.; Moller, D.E. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology, 1991, 129, 2058-2066.
25. Frasca, F.; Pandini, G.; Scalia, P.; Sciacca, L.; Mineo, R.; Costantino, A.; Goldfine, I.D.; Belfiore, A.; Vigneri, R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol., 1999, 19, 3278-3288.
26. Denley, A.; Bonython, E.R.; Booker, G.W.; Cosgrove, L.J.; Forbes, B.E.; Ward, C.W.; Wallace, J.C. Structural determinants for highaffinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol. Endocrinol., 2004, 18, 2502-2512.
27. Havrankova, J.; Roth, J.; Brownstein, M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature, 1978, 272, 827-829.
28. Abbott, M.A.; Wells, D.G.; Fallon, J.R. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J. Neurosci., 1999, 19, 7300-7308.
29. Unger, J.; McNeill, T.H.; Moxley, R.T. 3rd; White, M.; Moss, A.; Livingston, J.N. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience, 1989, 31(1), 143-157.
30. Rosen, O.M.; Herrera, R.; Olowe, Y.; Petruzzelli, L.M.; Cobb, M.H. Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc. Natl. Acad. Sci. USA, 1983, 80(11), 3237-3240.
31. Tornqvist, H.E.; Pierce, M.W.; Frackelton, A.R.; Nemenoff, R.A.; Avruch, J. Identification of insulin receptor tyrosine residues autophosphorylated in vitro. J. Biol. Chem., 1987, 262(21), 10212-10219.
32. White, M.F.; Shoelson, S.E.; Keutmann, H.; Kahn, C.R. A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem., 1988, 263(6), 2969-2980.
33. Wälchli, S.; Curchod, M.L.; Gobert, R.P.; Arkinstall, S.; Hooft van Huijsduijnen, R. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate-trapping" mutants. J. Biol. Chem., 2000, 275(13), 9792-9796.
34. Byon, J.C.; Kusari, A.B.; Kusari, J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol. Cell. Biochem., 1998, 182(1-2), 101-108.
35. Goldstein, B.J.; Bittner-Kowalczyk, A.; White, M.F.; Harbeck, M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B: possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J. Biol. Chem., 2000, 275(6), 4283-4289.
36. Picardi, P.K.; Calegari, V.C.; Prada Pde, O.; Moraes, J.C.; Araújo, E.; Marcondes, M.C.; Ueno, M.; Carvalheira, J.B.; Velloso, L.A.; Saad, M.J. Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats. Endocrinology, 2008, 149(8), 3870-3880.
37. Rajala, R.V.; Tanito, M.; Neel, B.G.; Rajala, A. Enhanced retinal insulin receptor-activated neuroprotective survival signal in mice lacking the protein-tyrosine phosphatase-1B gene. J. Biol. Chem., 2010, 285(12), 8894-8904.
38. Elchebly, M.; Payette, P.; Michaliszyn, E.; Cromlish, W.; Collins, S.; Loy, A.L.; Normandin, D.; Cheng, A.; Himms-Hagen, J.; Chan, C.C.; Ramachandran, C.; Gresser, M.J.; Tremblay, M.L.; Kennedy, B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science, 1999, 283(5407), 1544-1548.
39. Klaman, L.D.; Boss, O.; Peroni, O.D.; Kim, J.K.; Martino, J.L.; Zabolotny, J.M.; Moghal, N.; Lubkin, M.; Kim, Y.B.; Sharpe, A.H.; Stricker-Krongrad, A.; Shulman, G.I.; Neel, B.G.; Kahn, B.B. Increased energy expenditure, decreased adiposity, and tissuespecific insulin sensitivity in protein-tyrosine phosphatase 1Bdeficient mice. Mol. Cell. Biol., 2000, 20(15), 5479-5489.
40. Denu, J.M.; Tanner, K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry, 1998, 37(16), 5633-5642.
41. Barrett, W.C.; DeGnore, J.P.; Keng, Y.F.; Zhang, Z.Y.; Yim, M.B.; Chock, P.B. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J. Biol. Chem., 1999, 274(49), 34543-34546.
42. Lee, S.R.; Kwon, K.S.; Kim, S.R.; Rhee, S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem., 1998, 273(25), 15366-15372.
43. Barrett, W.C.; DeGnore, J.P.; König, S.; Fales, H.M.; Keng, Y.F.; Zhang, Z.Y.; Yim, M.B.; Chock, P.B. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry, 1999, 38(20), 6699-6705.
44. van Montfort, R.L.; Congreve, M.; Tisi, D.; Carr, R.; Jhoti, H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature, 2003, 423(6941), 773-777.
45. Salmeen, A.; Andersen, J.N.; Myers, M.P.; Meng, T.C.; Hinks, J.A.; Tonks, N.K.; Barford, D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature, 2003, 423(6941), 769-73.
46. Hwang, J.J.; Lim, J.H.; Kwon, J.H.; Lee, K.Y.; Hur, K.C. Effect of nerve growth factor, insulin, and extracellular matrix proteins on the neurite outgrowth of SK-N-BE(2) human neuroblastoma cells. Mol. Cells, 1995, 5, 501-507.
47. Seo, J.H.; Ahn, Y.; Lee, S.R.; Yeol Yeo, C.; Chung Hur, K. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol. Biol. Cell, 2005, 16(1), 348-357.
48. Hwang, J-J.; Hur, K.C. Insulin cannot activate extracellularsignalrelated kinase due to inability to generate reactive oxygen species in SK-N-BE(2) human neuroblastoma cells. Mol. Cells, 2005, 20(2), 280-287.
49. Jaillard, T.; Roger, M.; Galinier, A.; Guillou, P.; Benani, A.; Leloup, C.; Casteilla, L.; Pénicaud, L.; Lorsignol, A. Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidase-dependent mechanism. Diabetes, 2009, 58(7), 1544-1549.
50. Majander, A.; Finel, M.; Wikstrom, M. Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J. Biol. Chem., 1994, 269(33), 21037-21042.
51. Li, Y.; Trush, M.A. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun., 1998, 253(2), 295-299.
52. Liu, Y.; Fiskum, G.; Schubert, D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J. Neurochem., 2002, 80(5), 780-787.
53. Storozhevykh, T.P.; Senilova, Y.E.; Persiyantseva, N.A.; Pinelis, V.G.; Pomytkin, I.A. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. BMC Neuroscience, [Online] 2007, 8:84. BioMed Central. http://www.biomedcentral.com/1471-2202/8/84 [Accessed on: 8th October, 2007].
54. Chance, B.; Sies, H.; Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev., 1979, 59, 527-605.
55. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J., 2009, 417(1), 1-13.
56. Votyakova, T.V.; Reynolds, I.J. DeltaPsi(m)-Dependent and-independent production of reactive oxygen species by rat brain mitochondria. J. Neurochem., 2001, 79(2), 266-277.
57. Kudin, A.P.; Bimpong-Buta, N.Y.; Vielhaber, S.; Elger, C.E.; Kunz, W.S. Characterization of superoxide-producing sites in isolated brain mitochondria. J. Biol. Chem., 2004, 279(6), 4127-4135.
58. Han, D.; Canali, R.; Rettori, D.; Kaplowitz, N. Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol. Pharmacol., 2003, 64(5), 1136-1144.
59. Muller, F.L.; Liu, Y.; Abdul-Ghani, M.A.; Lustgarten, M.S.; Bhattacharya, A.; Jang, Y.C.; Van Remmen, H. High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I-and complex II-linked substrates. Biochem. J., 2008, 409(2), 491-499.
60. Fridovich, I. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J. Biol. Chem., 1997, 272(30), 18515-18517.
61. Okado-Matsumoto, A.; Fridovich, I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. J. Biol. Chem., 2001, 276, 38388-38393.
62. Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem., 1995, 64, 97-112.
63. Oberley, L.W. Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed. Pharmacother., 2005, 59, 143-148.
64. Cino, M.; Del Maestro, R.F. Generation of hydrogen peroxide by brain mitochondria: the effect of reoxygenation following postdecapitative ischemia. Arch. Biochem. Biophys., 1989, 269(2), 623-638.
65. Korshunov, S.S.; Skulachev, V.P.; Starkov, A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett., 1997, 416(1), 15-18.
66. Starkov, A.A.; Fiskum, G. Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state. J. Neurochem., 2003, 86(5), 1101-1107.
67. Korshunov, S.S.; Korkina, O.V.; Ruuge, E.K.; Skulachev, V.P.; Starkov, A.A. Fatty acids as natural uncouplers preventing generation of O2.-and H2O2 by mitochondria in the resting state. FEBS Lett., 1998, 435(2-3), 215-218.
68. Gutman, M.; Kearney, E.B.; Singer, T.P. Control of succinate dehydrogenase in mitochondria. Biochemistry, 1971, 10(25), 4763-4770.
69. Treberg, J.R.; Quinlan, C.L.; Brand, M.D. Evidence for two sites of superoxide production by mitochondrial NADH-ubiquinone oxidoreductase (complex I). J. Biol. Chem., 2011, 286(31), 27103-27110.
70. 2 release at mitochondrial complex I: negative modulation by malate, positive by cyanide. J. Bioenerg. Biomembr., 2009, 41(4), 387-393.
71. Pomytkin, I.A.; Kolesova, O.E. Effect of insulin on the rate of hydrogen peroxide generation in mitochondria. Bull. Exp. Biol. Med., 2003, 135(6), 541-542.
72. Wojtczak, L.; Wojtczak, A.B.; Ernster, L. The inhibition of succinate dehydrogenase by oxalacetate. Biochim. Biophys. Acta., 1969, 191(1), 10-21.
73. Ackrell, B.A.; Kearney, E.B.; Edmondson, D. Mechanism of the reductive activation of succinate dehydrogenase. J. Biol. Chem., 1975, 250(18), 7114-7119.
74. Ackrell, B.A.; Kearney, E.B.; Mayr, M. Role of oxalacetate in the regulation of mammalian succinate dehydrogenase. J. Biol. Chem., 1974, 249(7), 2021-2027.
75. Gutman, M.; Kearney, E.B.; Singer, T.P. Multiple control mechanisms for succinate dehydrogenase in mitochondria. Biochem. Biophys. Res. Commun., 1971, 44(3), 526-532.
76. Gutman, M.; Kearney, E.B.; Singer, T.P. Regulation of succinate dehydrogenase activity by reduced coenzymes Q10. Biochemistry, 1971, 10(14), 2726-2733.
77. Nulton-Persson, A.C.; Szweda, L.I. Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem., 2001, 276(26), 23357-23361.
78. Moser, M.D.; Matsuzaki, S.; Humphries, K.M. Inhibition of succinate-linked respiration and complex II activity by hydrogen peroxide. Arch. Biochem. Biophys., 2009, 488(1), 69-75.
79. Tretter, L.; Adam-Vizi, V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci., 2000, 20(24), 8972-8979.
80. Pomytkin, I.A.; Kolesova, O.E. Key role of succinate dehydrogenase in insulin-induced inactivation of protein tyrosine phosphatases. Bull. Exp. Biol. Med., 2002, 133(6), 568-570.
81. Komaromy-Hiller, G.; Sundquist, P.D.; Jacobsen, L.J.; Nuttall, K.L. Serum succinate by capillary zone electrophoresis: marker candidate for hypoxia. Ann. Clin. Lab. Sci., 1997, 27(2), 163-168.
82. Hochachka, P.W.; Dressendorfer, R.H. Succinate accumulation in man during exercise. Eur. J. Appl. Physiol. Occup. Physiol., 1976, 35(4), 235-242.
83. Bessman, S.P.; Mohan, C.; Zaidise, I. Intracellular site of insulin action: mitochondrial Krebs cycle. Proc. Natl. Acad. Sci. USA, 1986, 83(14), 5067-5070.
84. Navarro, A.; Boveris, A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol., 2007, 292(2), C670-686.
85. LaFrance, R., Brustovetsky, N., Sherburne, C., Delong, D., Dubinsky, J.M. Age-related changes in regional brain mitochondria from Fischer 344 rats. Aging Cell, 2005, 4(3), 139-145.
86. Xiong, J.; Verkhratsky, A.; Toescu, E.C. Changes in mitochondrial status associated with altered Ca2+ homeostasis in aged cerebellar granule neurons in brain slices. J. Neurosci., 2002, 22, 10761-10771.
87. Santos, R.X.; Correia, S.C.; Wang, X.; Perry, G.; Smith, M.A.; Moreira, P.I.; Zhu, X. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. Int. J. Clin. Exp. Pathol., 2010, 3(6), 570-581.
88. Moreira, P.I.; Duarte, A.I.; Santos, M.S.; Rego, A.C.; Oliveira, C.R. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. Alzheimers Dis., 2009, 16(4), 741-761.
89. Swerdlow, R.H.; Khan, S.M. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp. Neurol., 2009, 218(2), 308-315.
90. Sies, H. Oxidative stress: from basic research to clinical application. Am. J. Med., 1991, 91, 31S-38S.
91. Fatokun, A.A.; Stone, T.W.; Smith, R.A. Cell death in rat cerebellar granule neurons induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands. Brain. Res., 2007, 1132, 193-202.
92. Halliwell, B.; Gutteridge, J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol., 1990, 186, 1-85.
93. 2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J. Biol. Chem., 2010, 285(36), 27850-27858.
94. Erikson, K.M.; Pinero, D.J.; Connor, J.R.; Beard, J.L. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J. Nutr., 1997, 127(10), 2030-2038.
95. Park, S.; You, X.; Imlay, J.A. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpxmutants of Escherichia coli. Proc. Natl. Acad. Sci. USA., 2005, 102(26), 9317-9322.
96. Gardner, C.D.; Eguchi, S.; Reynolds, C.M.; Eguchi, K.; Frank, G.D.; Motley, E.D. Hydrogen peroxide inhibits insulin signaling in vascular smooth muscle cells. Exp. Biol. Med. (Maywood), 2003, 228(7), 836-842.
97. 2 in tumor necrosis factor alphamediated insulin resistance. J. Biol. Chem., 1999, 274(35), 25078-25084.
98. Cox, A.G.; Winterbourn, C.C.; Hampton, M.B. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J., 2009, 425(2), 313-325.
99. Adimora, N.J.; Jones, D.P.; Kemp, M.L. A model of redox kinetics implicates the thiol proteome in cellular hydrogen peroxide responses. Antioxid. Redox Signal., 2010, 13(6), 731-743.
100. 2 is not reflected in its reaction with other oxidants and thiol reagents. J. Biol. Chem., 2007, 282(16), 11885-11892.
101. Kletzien, R.F.; Harris, P.K.; Foellmi, L.A. Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J., 1994, 8(2), 174-181.
102. Regino, C.A.S.; Richardson, D.E. Bicarbonate-catalyzed hydrogen peroxide oxidation of cysteine and related thiols. Inorganica Chimica Acta, 2007, 360, 3971-3977.
103. Chiu, D.T.; Stults, F.H.; Tappel, A.L. Purification and properties of rat lung soluble glutathione peroxidase. Biochim. Biophys Acta, 1976, 445(3), 558-566.
104. McClung, J.P.; Roneker, C.A.; Mu, W.; Lisk, D.J.; Langlais, P.; Liu, F.; Lei, X.G. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc. Natl. Acad. Sci. USA, 2004, 101(24), 8852-8857.
105. Loh, K.; Deng, H.; Fukushima, A.; Cai, X.; Boivin, B.; Galic, S.; Bruce, C.; Shields, B.J.; Skiba, B.; Ooms, L.M.;; Stepto, N.; Wu, B.; Mitchell, C.A.; Tonks, N.K.; Watt, M.J.; Febbraio, M.A.; Crack, P. J,; Andrikopoulos, S.; Tiganis, T. Reactive oxygen species enhance insulin sensitivity. Cell Metab., 2009, 10(4), 260-272.
106. Craft, S. Insulin resistance syndrome and Alzheimer's disease: ageand obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging, 2005, 26(Suppl 1), 65-69.
107. Frolich, L.; Blum-Degen, D.; Bernstein, H.G.; Engelsberger, S.; Humrich, J.; Laufer, S.; Muschner, D.; Thalheimer, A.; Turk, A.; Hoyer, S.; Zochling, R.; Boissl, K.W.; Jellinger, K.; Riederer, P. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural. Transm., 1998, 105, 423-438.
108. Hoyer, S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur. J. Pharmacol., 2004, 490(1-3), 115-125.
109. de la Monte, S.M. Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Front. Biosci. (Elite Ed)., 2012, 4, 1582-1605.
110. Zhu, X.; Raina, A.K.; Lee, H.G.; Casadesus, G.; Smith, M.A.; Perry, G. Oxidative stress signalling in Alzheimer's disease. Brain Res., 2004, 1000(1-2), 32-39.
111. Moreira, P.I.; Zhu, X.; Liu, Q.; Honda, K.; Siedlak, S.L.; Harris, P.L.; Smith, M.A.; Perry, G. Compensatory responses induced by oxidative stress in Alzheimer disease. Biol. Res., 2006, 39(1), 7-13.
112. Bonda, D.J.; Wang, X.; Perry, G.; Nunomura, A.; Tabaton, M.; Zhu, X.; Smith, M.A. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology, 2010, 59(4-5), 290-294.
113. Martins, R.N.; Harper, C.G.; Stokes, G.B.; Masters, C.L. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem., 1986, 46(4), 1042-1045.
114. Palmer, A.M. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J. Neural. Transm., 1999, 106(3-4), 317-328.
115. Russell, R.L.; Siedlak, S.L.; Raina, A.K.; Bautista, J.M.; Smith, M.A.; Perry, G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch. Biochem. Biophys., 1999, 370(2), 236-239.
116. Aksenov, M.Y.; Tucker, H.M.; Nair, P.; Aksenova, M.V.; Butterfield, D.A.; Estus, S.; Markesbery, W.R. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J. Mol. Neurosci., 1998, 11, 151-164.
117. Aksenov, M.Y.; Markesbery, W.R. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci. Lett., 2001, 302(2-3), 141-145.
118. Kim, S.H.; Fountoulakis, M.; Cairns, N.; Lubec, G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J. Neural. Transm. Suppl., 2001, 61, 223-235.
119. Cumming, R.C.; Dargusch, R.; Fischer, W.H.; Schubert, D. Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J. Biol. Chem., 2007, 282(42), 30523-30534.
120. Krapfenbauer, K.; Engidawork, E.; Cairns, N.; Fountoulakis, M.; Lubec, G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res., 2003, 967(1-2), 152-160.
121. Sultana, R.; Boyd-Kimball, D.; Cai, J.; Pierce, W.M.; Klein, J.B.; Merchant, M.; Butterfield, D.A. Proteomics analysis of the Alzheimer's disease hippocampal proteome. J. Alzheimers Dis., 2007, 11(2), 153-164.
122. Power, J.H.; Asad, S.; Chataway, T.K.; Chegini, F.; Manavis, J.; Temlett, J.A.; Jensen, P.H.; Blumbergs, P.C.; Gai, W.P. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology. Acta Neuropathol., 2008, 115(6), 611-622.
123. Roses, A.D.; Saunders, A.M.; Huang, Y.; Strum, J.; Weisgraber, K.H.; Mahley, R.W. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenom. J., 2007, 7(1), 10-28.
124. Strum, J.C.; Shehee, R.; Virley, D.; Richardson, J.; Mattie, M.; Selley, P.; Ghosh, S.; Nock, C.; Saunders, A.; Roses, A. Rosiglitazone induces mitochondrial biogenesis in mouse brain. J. Alzheimers Dis., 2007, 11(1), 45-51.
125. Pedersen, W.A.; Flynn, E.R. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis., 2004, 17(3), 500-506.
126. Watson, G.S.; Cholerton, B.A.; Reger, M.A.; Baker, L.D.; Plymate, S.R.; Asthana, S.; Fishel, M.A.; Kulstad, J.J.; Green, P.S.; Cook, D.G.; Kahn, S.E.; Keeling, M.L.; Craft, S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am. J. Geriatr. Psychiatry., 2005, 13(11), 950-958.
127. Risner, M.E.; Saunders, A.M.; Altman, J.F.; Ormandy, G.C.; Craft, S.; Foley, I.M.; Zvartau-Hind, M.E.; Hosford, D.A.; Roses, A.D.; Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-tomoderate Alzheimer's disease. Pharmacogenom. J., 2006, 6(4), 246-254.